Page last updated: 2024-10-27

gabapentin and Chronic Inflammatory Demyelinating Polyradiculoneuropathy

gabapentin has been researched along with Chronic Inflammatory Demyelinating Polyradiculoneuropathy in 1 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Research Excerpts

ExcerptRelevanceReference
"Healthcare costs for CIDP patients are substantial, with a large burden in pharmacy usage."1.40Patient demographics and health plan paid costs in chronic inflammatory demyelinating polyneuropathy. ( Bromberg, MB; Guptill, JT; Krueger, A; Sanders, DB; Sharma, BK; Thompson, AR; Zhu, L, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guptill, JT1
Bromberg, MB1
Zhu, L1
Sharma, BK1
Thompson, AR1
Krueger, A1
Sanders, DB1

Other Studies

1 other study available for gabapentin and Chronic Inflammatory Demyelinating Polyradiculoneuropathy

ArticleYear
Patient demographics and health plan paid costs in chronic inflammatory demyelinating polyneuropathy.
    Muscle & nerve, 2014, Volume: 50, Issue:1

    Topics: Adolescent; Adult; Aged; Algorithms; Amines; Analgesics; Anti-Inflammatory Agents; Comorbidity; Cost

2014